Targeted Therapy Shows Benefit in Rare Type of Thyroid Cancer
Treatment with the multitargeted agent vandetanib (Caprelsa) improved progression-free survival in patients with medullary thyroid cancer (MTC), according to findings from a randomized clinical trial. Earlier this year, the Food and Drug Administration (FDA) approved vandetanib for the treatment of patients with MTC based on initial findings from the phase III trial. MTC is a rare cancer, accounting for only 5 percent of all thyroid cancer cases, and radiation and chemotherapy have limited effects once the cancer progresses to an advanced stage.![]()
NCI Cancer Bulletin
Prepackaged (7 3/4 in.) Cancer Awareness Bracelet 18 Colors, 8mmProduct Description
Our Bracelets are Handmade in the USA. Made with 8mm cats eye beads (the red bead here is a glass pearl, not a…
Breast Cancer Pink Ribbon Lanyard – RETAILThis pink ribbon lanyard has dark pink ribbons along with the words “Find The Cure” in white letters. Can act as a keychain or bad…
Targeted Therapy Promising For Cancer Patients
Casey Carleton, a patient with metastatic melanoma explains his experience and success on Phase 1 clinical trial. Customizing targeted therapies to each tumor’s molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center. bit.ly
Video Rating: 5 / 5

Video Rating: 0 / 5
Aromatase Inhibitors: Types, Mode of Action and Indications (Cancer Etiology, Diagnosis and Treatment Series)Aromatase inhibitors (AI) are a class of drugs used in the treatment of breast cancer and ovarian cancer in postmenopausal women. …
Hephaestus Books represents a new publishing paradigm, allowing disparate content sources to be curated into cohesive, relevant, a…
The Type C Connection: The Behavioral Links to Cancer and Your HealthA look at the connection between specific behavior patterns and cancer argues that the type C personality–someone who is pleasant…
Comparing Targeted Lung Cancer Therapies Based on KRAS Mutation Status
The anticancer drug erlotinib (Tarceva) is considered a standard therapy for patients with advanced non-small cell lung cancer (NSCLC) that has progressed after treatment with chemotherapy. Unfortunately, erlotinib has shown little benefit for NSCLC patients whose tumors have a mutated form of the gene KRAS; about 20 percent of NSCLC patients in the United States have tumors with KRAS mutations. Therefore, doctors are interested in finding other treatments that may help patients with KRAS-mutated NSCLC.![]()
NCI Cancer Bulletin
The Breast Cancer Prevention Program“A marvelous book—intelligent, courageous, and practical.” —Barbara Seaman, co-founder, National Women’s Health Network What Y…
Cancer Causes and Controversies: Understanding Risk Reduction and PreventionLike no other work, this much-needed volume gathers the latest research and understanding about the causes of cancer and methods o…
Obesity Cancer & Depression: Their Common Cause & Natural CureThis book, the result of over 20 years of research, looks at the conditions of obesity, cancer and depression through a new physio…
Categories: Cancer Causes Tags: Based, Cancer, Comparing, KRAS, Lung, Mutation, Status, Targeted, Therapies
Blocking cancer cell’s energy ‘generator’ could lead to new targeted treatments
Scientists in the UK have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones.
ScienceDaily: Cancer News
Hanging Out With Lab Coats: Hope, Humor & Help for Cancer Patients and their CaregiversWendi Fox Pedicone became a cancer statistic in August 2004 when she was diagnosed with advanced stage breast cancer. With a treme…
Nutrition for Cancer Recovery: Comfort Care Soup and Bread AssortmentOur Soup and Bread Assortment contains:
* 1 jar Beef Barley Soup
* 1 jar Heartland Chicken Soup
* 1 jar Tomato Cheddar Jack So…
What to Eat Now: The Cancer Lifeline Cookbook : And Easy-To-Use Nutrition Guide to Delicious and Healthy Eating for Cancer Patients, Survivors, and CaregiversAfter 23 years of supporting cancer survivors and their families, Cancer Lifeline presents What to Eat Now. With practical easy-t…
Categories: Cancer Caregiver Tags: Blocking, Cancer, cell’s, Could, Energy, lead, Targeted, Treatments, ‘generator’
Matching targeted therapies to tumor’s specific gene mutations key to personalized cancer treatment
Customizing targeted therapies to each tumor’s molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to researchers.
ScienceDaily: Cancer News
Comfort For The Caregiver Gift BasketAt Healing In Harmony, the original impetus for the baskets was that of support for a person challenged by disease, the need for c…
Everyone’s Guide to Cancer Supportive Care: A Comprehensive handbook for Patients and Their FamiliesThis new companion book to AMP’s highly successful Everyone’s Guide to Cancer Therapy, now in its fourth edition, is a comprehensi…
Better & Better Series with Elizabeth Hepburn 3 Volume Set: Volume I: Pre-Surgery Healing Programs for PATIENT and CAREGIVER, Volume II: Post-Surgery Healing Programs for PATIENT and CAREGIVER, Volume III: In the Lap of Luxury. Each Volume contains DVD, CD, and Guidebook.Better and Better Series with Elizabeth Hepburn. All 3 Volumes Included. Volume I and Volume II, contains 2 DVDs, 2 CDs, and 2 Gui…
Categories: Cancer Caregiver Tags: Cancer, Gene, Matching, Mutations, Personalized, specific, Targeted, Therapies, treatment, Tumors
Clavis Pharma Receives Government Grant To Develop HENT1 Biomarker Assay For Targeted Therapy Of AML Patients
Clavis Pharma ASA (OSE: CLAVIS), the Norwegian cancer drug development company, is pleased to announce that it has been awarded a grant from The Research Council of Norway of up to NOK 14 mill (USD 2…
Cancer / Oncology News From Medical News Today
Complementary and Integrative Medicine in Cancer Care And Prevention: Foundations And Evidence-based InterventionsProvide whole care to your cancer patients with: Up-to-date information on the uses of diet, nutrition, and herbs Elucidations…
Live Strong: Inspirational Stories from Cancer Survivors-from Diagnosis to Treatment and BeyondSince the now ubiquitous LIVESTRONG™ wristbands became available in May 2004, the Lance Armstrong Foundation has raised more tha…
Categories: Cancer Foundation Tags: Assay, Biomarker, Clavis, Develop, Government, Grant, HENT1, Patients, Pharma, Receives, Targeted, therapy
A New Study On Self-Injury Behavior Encourages Quick And Targeted Intervention
While the disturbing act of self-injury is nothing new to adolescents, researchers and physicians at Nationwide Children’s Hospital have identified a more severe type of behavior that is raising some concern among medical professionals. Often misdiagnosed, ignored and under-reported, Self-Embedding Behavior (SEB) is a form of self-injurious behavior that involves inserting foreign objects into soft tissue – either under the skin or into muscle…


![]()
Health News from Medical News Today
Stem Cells and Cancer (Cancer Drug Discovery and Development)Significance of Stem Cells to Tumor Development Cancer stem cells remain a controversial topic and the criteria that define can…
Handbook of Anticancer Drug DevelopmentWritten by leading investigators from academia and the pharmaceutical industry, this volume is a comprehensive, practical guide f…
Categories: Cancer Drugs Tags: Behavior, Encourages, Intervention, Quick, SelfInjury, Study, Targeted
Featured Clinical Trial: Targeted Antibody Therapy for Metastatic Adrenocortical Carcinoma
The name of the trial is Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults with Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma (NCI-10-C-0052).![]()
NCI Cancer Bulletin
Danger Sign – Contains MDA May Cause Cancer Liver Toxin – 10″ x 14″ OSHA Safety SignKeep your facility safe with this OSHA regulated sign. This sign is 10″ x 14″ polystyrene (.050 rigid plastic) designed for long l…
Just Cause BREAST CANCER AWARENESS Stretch Charm BraceletRound pink glass beads stretch bracelet with dangling Silver Ribbon charm. Meaures 8″ before stretch begins – stretchy to fil ever…
Fox Run Pink Ribbon “Baking for a Cause” Gift SetSupport breast cancer awareness in a surprisingly sweet way with this set of three items to really get your bake sale going. The p…
Categories: Cancer Causes Tags: Adrenocortical, Antibody, Carcinoma, Clinical, Featured, Metastatic, Targeted, therapy, Trial
BIND Biosciences Initiates Phase 1 Clinical Study Of BIND-014, A First-In-Class Targeted Nanoparticle Therapeutic For Cancer
BIND Biosciences announced today that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of BIND-014 in cancer patients. BIND-014, the first product candidate to enter clinical evaluation from BIND’s broad proprietary Medicinal Nanoengineering platform, is a targeted polymeric nanoparticle containing the cytotoxic agent, docetaxel…
Cancer / Oncology News From Medical News Today
Master Lock 1530DPNK Breast Cancer Research Foundation Dial Combination Lock, PinkMaster Lock Round Dial Combination PadlockShow your support and help find a cure for breast cancer; Aluminumcover with durable ano…
SABRE Compact Pepper Spray with Pink Key Case – Supports National Breast Cancer FoundationCool style and hot protection are combined in SABRE’s most popular product. This attractive, pink compact pepper spray delivers a…
Categories: Cancer Foundation Tags: BIND, BIND014, Biosciences, Cancer, Clinical, FirstInClass, Initiates, Nanoparticle, Phase, Study, Targeted, Therapeutic





